Relmada Therapeutics, Inc. (NASDAQ:RLMD)

About the company

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. It engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases and other disorders. The company was founded on May 31, 2012 and is headquartered in New York, NY.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

4

CEO

Sergio Traversa

Exchange

NASDAQ

Website

http://www.relmada.com

$0.00M

Total Revenue

4

Employees

$380.88M

Market Capitalization

-31.82

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 381445.74 82729.00 6.13 22.23 20.75
Merck & Co., Inc. MRK 196786.55 48081.00 7.39 19.42 21.10
Pfizer Inc. PFE 188747.85 50660.00 2.86 11.95 31.17
Eli Lilly & Co. LLY 151075.27 23087.00 51.27 26.63 23.97
AbbVie, Inc. ABBV 145342.96 34057.00 -23.26 17.33 24.65
Bristol Myers Squibb Co. BMY 108491.37 31006.00 2.63 92.24 3.08
Repligen Corp. RGEN 6389.28 286.00 6.13 278.40 8.11
Reata Pharmaceuticals, Inc. RETA 4839.72 20.00 22.93 -15.57 -150.30
Nektar Therapeutics NKTR 4363.04 137.00 3.41 -9.50 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3946.28 1.00 36.49 -6.04 None
Allakos, Inc. ALLK 3152.76 None 6.84 -33.71 None
ADC Therapeutics SA ADCT 2565.54 2.00 30.26 -22.00 None
Karuna Therapeutics, Inc. KRTX 2485.08 None 6.49 -61.27 None
OPKO Health, Inc. OPK 2448.18 891.00 1.74 -8.37 -32.92
Turning Point Therapeutics, Inc. TPTX 2259.72 None 6.80 -18.91 None
IGM Biosciences, Inc. IGMS 2221.15 None 9.79 -40.94 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Apellis Pharmaceuticals, Inc. APLS 2094.84 None 9.25 -5.02 None
Springworks Therapeutics, Inc. SWTX 1695.06 None 5.51 -27.19 None
Principia Biopharma, Inc. PRNB 1578.64 30.00 5.62 -22.46 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1495.17 None 9.16 -16.23 None
Zymeworks, Inc. ZYME 1473.78 26.00 3.06 -8.69 -629.37
Tricida, Inc. TCDA 1300.46 None 6.69 -6.16 None
Akcea Therapeutics, Inc. AKCA 1289.13 341.00 2.65 -45.83 -8.59
Kiniksa Pharmaceuticals Ltd. KNSA 1267.20 None 6.56 -10.47 None
Akero Therapeutics, Inc. AKRO 1138.62 None 9.51 -22.44 None
Odonate Therapeutics, Inc. ODT 1127.52 None 9.24 -10.02 None
Arcutis Biotherapeutics, Inc. ARQT 1074.85 None 4.58 -17.19 None
Phibro Animal Health Corp. PAHC 1060.26 818.00 5.35 28.73 4.49
Athenex, Inc. ATNX 1014.78 123.00 6.22 -9.43 -87.86
Constellation Pharmaceuticals, Inc. CNST 932.16 None 4.39 -10.04 None
G1 Therapeutics, Inc. GTHX 811.30 1.00 3.51 -6.19 None
Gossamer Bio, Inc. GOSS 809.47 None 3.28 -4.07 None
Phathom Pharmaceuticals, Inc. PHAT 750.75 None 4.17 -2.76 None
Quanterix Corp. QTRX 742.50 60.00 6.55 -16.98 -71.52
Krystal Biotech, Inc. KRYS 721.31 None 4.21 -34.78 None
Oric Pharmaceuticals, Inc. ORIC 687.96 None -7.47 -22.75 None
Applied Therapeutics, Inc. APLT 686.84 14.00 4.43 -13.94 -19.41
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Aprea Therapeutics, Inc. APRE 647.22 None 5.73 -19.14 None
Arcturus Therapeutics Holdings, Inc. ARCT 632.06 19.00 58.58 -22.72 -151.34
Amneal Pharmaceuticals, Inc. AMRX 617.87 1679.00 4.25 -2.84 -11.85
Keros Therapeutics, Inc. KROS 601.74 8.00 -27.18 -28.33 -285.35
Oyster Point Pharma, Inc. OYST 546.00 None 5.49 -9.49 None
Mirum Pharmaceuticals, Inc. MIRM 491.75 None 3.20 -7.26 None
SIGA Technologies, Inc. SIGA 467.40 19.00 5.23 -23.75 -94.00
89bio, Inc. ETNB 457.80 None 5.65 -7.09 None
Fulcrum Therapeutics, Inc. FULC 444.13 1.00 7.48 -6.44 None
Osmotica Pharmaceuticals Plc OSMT 442.80 232.00 3.36 -1.61 -115.44
Biospecifics Technologies Corp. BSTC 442.54 40.00 3.59 18.93 61.80
Satsuma Pharmaceuticals, Inc. STSA 441.32 None 4.34 -12.13 None
Imara, Inc. IMRA 395.33 None 3.82 -11.23 None
DURECT Corp. DRRX 394.04 28.00 30.26 -16.30 -82.94
TCR2 Therapeutics, Inc. TCRR 383.04 None 2.62 -38.00 None
Kala Pharmaceuticals, Inc. KALA 383.04 6.00 4.19 -4.17 None
Relmada Therapeutics, Inc. RLMD 380.88 0.00 5.68 -31.82 -877.66
Crinetics Pharmaceuticals, Inc. CRNX 376.08 1.00 4.75 -6.45 -447.78
Ocular Therapeutix, Inc. OCUL 357.12 6.00 -43.76 -3.90 None
Ovid Therapeutics, Inc. OVID 349.65 None 8.27 -5.36 None
Aeglea Biotherapeutics, Inc. AGLE 303.27 4.00 9.57 -3.78 -523.27
Urovant Sciences Ltd. UROV 285.60 None -5.06 -1.98 None
IDEAYA Biosciences, Inc. IDYA 270.40 None 4.11 -6.20 None
Spero Therapeutics, Inc. SPRO 268.28 12.00 3.53 -3.30 -656.72
HOOKIPA Pharma, Inc. HOOK 267.80 13.00 2.42 -5.92 -333.02
Gritstone Oncology, Inc. GRTS 255.60 4.00 2.29 -2.45 None
AMAG Pharmaceuticals, Inc. AMAG 240.04 321.00 0.92 -0.65 -115.05
Lannett Co., Inc. LCI 234.84 542.00 0.80 -7.72 -5.77
KalVista Pharmaceuticals, Inc. KALV 224.64 12.00 2.48 -6.93 -263.38
Verrica Pharmaceuticals, Inc. VRCA 219.00 None 4.00 -7.18 None
Kaleido Biosciences, Inc. KLDO 207.90 None 7.37 -2.84 None
Sutro Biopharma, Inc. STRO 200.79 41.00 3.81 -3.29 -148.06
Veru, Inc. VERU 200.20 39.00 6.70 -20.53 -25.53
Galera Therapeutics, Inc. GRTX 187.25 None 3.50 -2.85 None
LogicBio Therapeutics, Inc. LOGC 175.03 1.00 5.28 -4.11 None
Protara Therapeutics, Inc. TARA 173.10 None 2.60 -11.23 None
Liquidia Technologies, Inc. LQDA 166.10 8.00 13.02 -3.37 -602.17
Avenue Therapeutics, Inc. ATXI 156.00 532.00 28.68 -10.71 26.69
Cyclerion Therapeutics, Inc. CYCN 153.49 6.00 1.93 -1.48 None
Corvus Pharmaceuticals, Inc. CRVS 147.45 None 2.36 -3.12 None
Lyra Therapeutics, Inc. LYRA 145.68 1.00 -1.24 -8.73 -491.16
Tyme Technologies, Inc. TYME 144.90 None 8.40 -6.63 None
scPharmaceuticals, Inc. SCPH 143.36 119.00 3.66 -4.57 -27.05
Evelo Biosciences, Inc. EVLO 140.80 None 5.18 -1.61 None
PhaseBio Pharmaceuticals, Inc. PHAS 134.85 2.00 2.50 -2.82 None
Aquestive Therapeutics, Inc. AQST 128.24 49.00 -7.39 -1.82 -139.64
Mustang Bio, Inc. MBIO 125.60 None 2.93 -2.55 None
Harrow Health, Inc. HROW 122.46 51.00 7.85 -4.96 -47.54
TFF Pharmaceuticals, Inc. TFFP 117.80 None 4.56 -3.04 None
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
NeuBase Therapeutics, Inc. NBSE 117.04 None 49.18 -2.62 None
Ayala Pharmaceuticals, Inc. AYLA 112.20 3.00 -2.64 -5.44 -679.19
Evolus, Inc. EOLS 100.50 45.00 1.80 -0.99 -217.51
Eton Pharmaceuticals, Inc. ETON 94.32 1.00 10.27 -4.72 None
Milestone Pharmaceuticals, Inc. MIST 93.86 None 0.93 -1.51 None
Trevi Therapeutics, Inc. TRVI 93.60 None 1.98 -3.19 None
EyePoint Pharmaceuticals, Inc. EYPT 78.49 26.00 5.54 -1.60 -196.30
Checkpoint Therapeutics, Inc. CKPT 76.80 2.00 6.62 -3.31 -949.53
Clearside Biomedical, Inc. CLSD 72.57 6.00 9.32 -4.12 -293.61
Xeris Pharmaceuticals, Inc. XERS 72.24 4.00 3.58 -0.56 None
Navidea Biopharmaceuticals, Inc. NAVB 68.17 1.00 -50.13 -6.17 -65.13
Baudax Bio, Inc. BXRX 63.54 None -1.73 -0.91 None
BiomX, Inc. PHGE 60.06 None 1.58 -1.40 None
Genprex, Inc. GNPX 59.60 None 5.06 -4.36 None
Assertio Therapeutics, Inc. ASRT 57.60 192.00 1.00 -0.35 -83.99
Aridis Pharmaceuticals, Inc. ARDS 55.44 1.00 -22.81 -1.90 -851.00
Aerpio Pharmaceuticals, Inc. ARPO 54.12 20.00 1.63 -2.87 -51.58
Menlo Therapeutics, Inc. MNLO 48.72 2.00 4.10 -0.52 -483.51
Eyenovia, Inc. EYEN 45.12 None 4.55 -2.20 None
Edesa Biotech, Inc. EDSA 44.01 0.00 6.27 -0.46 -395.23
Annovis Bio, Inc. ANVS 42.49 None 3.89 -33.72 None
Moleculin Biotech, Inc. MBRX 40.48 None 3.52 -4.40 None
Acer Therapeutics, Inc. ACER 36.30 3.00 2.65 -1.39 -274.69
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Citius Pharmaceuticals, Inc. CTXR 34.83 None 2.58 -2.02 None
AgeX Therapeutics, Inc. AGE 33.82 2.00 -44.50 -2.78 -658.11
Oncternal Therapeutics, Inc. ONCT 33.67 3.00 4.32 -1.34 -225.89
Mannatech, Inc. MTEX 33.40 156.00 1.41 7.52 3.45
Allena Pharmaceuticals, Inc. ALNA 33.35 None 4.39 -0.77 None
Aileron Therapeutics, Inc. ALRN 30.80 None 4.23 -1.16 None
Adamis Pharmaceuticals Corp. ADMP 30.16 22.00 1.16 -1.02 -140.33
CNS Pharmaceuticals, Inc. CNSP 29.28 None 5.08 -5.38 None
Hoth Therapeutics, Inc. HOTH 25.40 None 7.06 -2.82 None
Millendo Therapeutics, Inc. MLND 25.20 0.00 0.59 -0.54 None
Spring Bank Pharmaceuticals, Inc. SBPH 24.77 0.00 0.94 -0.95 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 19.76 1.00 8.67 -1.18 None
ProPhase Labs, Inc. PRPH 16.92 9.00 1.53 -5.64 -31.15
Adial Pharmaceuticals, Inc. ADIL 14.80 None 3.61 -1.95 None
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Novan, Inc. NOVN 14.38 5.00 -3.31 -0.46 -602.34
PDS Biotechnology Corp. PDSB 13.93 None 1.54 -0.55 None
Titan Pharmaceuticals, Inc. TTNP 12.07 4.00 5.03 -0.67 -437.91
Novus Therapeutics, Inc. NVUS 8.01 None 0.69 -0.38 None
Brickell Biotech, Inc. BBI 4.68 5.00 1.53 -0.06 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Relmada Therapeutics Inc.

3d ago, source: MarketWatch

10/11/2019 N/A S-1/A Registration Statement * 08/12/2019 N/A S-1 Registration Statement 05/15/2019 N/A S-8 Registration Statement 02/26/2019 N/A S-1/A Registration Statement * 01/14/2019 N/A S-1 ...

Invesco Ltd. Has $9.08 Million Position in Relmada Therapeutics Inc (OTCMKTS:RLMD)

4d ago, source: theenterpriseleader.com

Invesco Ltd. lowered its position in Relmada Therapeutics Inc (OTCMKTS:RLMD) by 1.2% in the first quarter, according to the ...

Hedge Funds Are Nibbling On Relmada Therapeutics, Inc. (RLMD)

15d ago, source: YAHOO!

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use ...

Is It Too Late to Buy These 3 Pharmaceutical Stocks?

3d ago, source: The Motley Fool

The question now is, how much higher can any of them go from here? Shares of Relmada Therapeutics (NASDAQ:RLMD) have risen more than 484% in the past year. The New York City-based clinical-stage ...

Relmada Therapeutics Announces Notice of Allowance for Patent in Canada Covering REL-1017 for Treatment of Psychiatric Symptoms

17d ago, source: YAHOO!

Relmada Therapeutics Announces Notice of Allowance for Patent in Canada Covering REL-1017 for Treatment of Psychiatric ...

BRIEF-Relmada Therapeutics Announces Notice Of Allowance For Patent In Canada

17d ago, source: Reuters

RELMADA THERAPEUTICS ANNOUNCES NOTICE OF ALLOWANCE FOR PATENT IN CANADA COVERING REL-1017 FOR TREATMENT OF PSYCHIATRIC SYMPTOMS Source text for Eikon: Further company coverage: Our Standards:The ...

Pharmaceuticals: Major Stocks

24d ago, source: U.S. News & World Report

more Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. It engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.